150 mg Paxista is an oral pharmaceutical formulation designed for prescribed therapeutic use as directed by healthcare professionals. It is intended to support specific treatment protocols depending on the medical condition being addressed. The medication is manufactured under controlled quality standards and is meant for use only under medical supervision to ensure appropriate dosage and safety compliance.
150 mg Paxista Features:
| Form | Oral Film-coated Tablets |
| Brand Name | Paxista |
| Therapeutic Class | SSRI |
| Manufacture By | Azista Industries (Azista Healthcare) |
| Shelf Life | 24 Months |
| Tablet Count (per Box) | Contains 30 Tablets |
| Strength | 150 Mg |
| Dosing Frequency | Taken Orally Twice Daily |
| Treatment Duration | Complete 5-day Treatment Course Required |
| Prescription Status | Prescription Medicine |
| Storage Requirement | Store At Room Temperature (20- 25°C) |
| Route Of Administration | Oral |
| Packaging Type | Box Containing Blister Packs (strips) |
| Manufacturing Standard | GMP Certified Facility |
| Target Population | Adults And Pediatric Patients |
| Supply Category | Pharmaceutical Wholesale |
| Exporter By | Shreshta Pharma |
| Origin | Made In India |
Copyright © 2026 Shreshta Pharma All Rights Reserved.
